search
for
 About Bioline  All Journals  Testimonials  Membership  News


International Journal of Reproductive BioMedicine
Research and Clinical Center for Infertility, Shahid Sadoughi University of Medical Sciences of Yazd
ISSN: 1680-6433 EISSN: 2008-2177
Vol. 5, Num. 2, 2007, pp. 77-79

Iranian Journal of Reproductive Medicine, Vol. 5, No.2, Spring 2007, pp. 77-79

Case report

Fallopian tube endometrioid carcinoma

Ahmad Mohammad Ragab Shalaby  M.D.

Oncologic Pathology Department, Damanhour National Medical Institute, El-Behera, Egypt.
Correspondence Author: Dr Ahmad Mohammad Ragab Shalaby,Damanhour National Medical Institute, Oncologic Pathology Department, 1 Ismail Sedky Street, El-Hofy, Building,Damanhour, El-Behera, Egypt. E-mail: ahmad_shalaby20@yahoo.com

Received: 4 December 2006; accepted: 25 April 2007

Code Number: rm07018

Abstract

Background: Carcinoma of the fallopian tube is extremely uncommon neoplasm, accounting for only 0.3% of gynecologic cancers.
Case: A 17-year-old female patient presented with clinical symptoms of right side deep pelvic pain. Ultrasound examination reveals right adenxal mass with breakdown suggesting neoplastic lesion or tubo-ovarian abscess. She was diagnosed clinically as tubo-ovarian mass for histopathological verification of its nature and prepared for surgery. There was a large soft tissue lesion arising in the middle of the right fallopian tube. Histopathological analysis of the specimen revealed neoplastic growth formed of malignant glands and acini of endometrioid pattern.
Conclusion: Most tubal endometrioid carcinomas resemble the endometrial counterpart histologically. Involvement of tubal serosa, of the ovary or corpus uteri or other pelvic and abdominal structures indicate a poor prognosis.

Key Words: Endometrial carcinoma, Fallopian tube, Gynecological cancers.

Introduction

Carcinoma of the fallopian tube is extremely uncommon neoplasm, accounting for only 0.3% of gynecologic cancer(1),but this figure may be low because carcinomas of uncertain origin involving both the ovary and the tube are generally classified as ovarian in view of their much higher overall frequency. In support of a higher frequency of tubal carcinoma than the figure just cited is a screening study using CA-125 assays that detected one tubal carcinoma for every six ovarian carcinomas (2-4).

Case Report 

A 17-year-old female patient presented with clinical symptoms of right side deep pelvic pain and recurrent attacks of lower abdominal colic with a history of intermittent, profuse, watery, and clear to turbid yellow vaginal discharge over duration of six months. Routine hematological and biochemical investigations were performed for her but the results were within the normal limits. Ultrasound examination reveals right adenxal mass with breakdown suggesting neoplastic lesion or tubo-ovarian abscess. She was diagnosed clinically as tubo-ovarian mass for histopathological verification of its nature and prepared for surgery. The surprise was in that, the ovary was completely free from any pathological lesion but there was a large soft tissue lesion arising in the middle of the right fallopian tube. The tube was excised and sent for the pathology department. The patient was discharged on the next week. The pathology results revealed a large fusiform swelling which measured 12x9x7 cm in dimensions arising from middle third of the fallopian tube; leaving both the fimbrial and the uterine ends unaffected grossly (Figure I). On cut section, we found the lesion completely obstructing the lumen of the tube and appearing as a single solid mass distending and infiltrating the wall at the affected part of the tube. The tumor tissue varied in color from tan to yellow to white in cut section and firm in consistency; in general. The external surface was smooth; glistening and not penetrated the serosal surface of the tube but shows many congested blood vessels. 

Histopathological analysis of the specimen revealed neoplastic growth formed of malignant glands and acini of endometrioid pattern (Figure 2) similar to the uterine counter part in slides prepared from the tumor area. The tumor also showed other morphological patterns as it contained solid areas and papillary foci (Figure 3) in other places, but no necrosis could be detected although serial sectioning of the specimen was achieved. The fimbrial end (Figure 4), ampullary region (Figure 5) and the uterine end were completely free from tumor invasion.

 Discussion

The classic complaint of intermittent, profuse, watery, clear to turbid yellow vaginal discharge accompanied by colicky abdominal pain and followed by decrease in the size of the abdominal mass (hydrops tubae profluens) is encountered in only a minority of the cases (less than 10%).The diagnosis is usually unsuspected preoperatively (5,6).A rare case of carcinoma in situ of fallopian tube has been reported after tamoxafen therapy (5).  On the bases of the cases reported in the literature, about 50% of tubal carcinomas are serous, about one-quarter endometrioid, one-fifth transitional or undifferentiated and the remainders are other epithelial types (6,7). Endometrioid carcinoma which is the second commonest subtype of tubal carcinoma is important to recognize because it carries the best prognosis of tubal cancers (6, 7).

Most tubal endometrioid carcinomas resemble the endometrial counterpart histologically and it may be associated with endometriosis, squamous metaplasia or prominent spindle epithelial cell component but this should not lead to mis-diagnosis as carcinosarcoma (7, 8).Involvement of tubal serosa, of the ovary or corpus uteri or other pelvic and abdominal structures indicates a poor prognosis (8- 10).

Acknowledgements 

We thank Professor Nayera Anwar AbdAl-Hameid, Professor Nadia Mahmoud Mokhtar and Professor Magda Murad (Professors ofOncologic Pathology in National Cancer Institute, Cairo University) for their great help and advise that make this work possible.

References

  1. Benedet JL, White GW. Malignant tumor fallopian tube. In: Coppleson M, ed. Gynecologic Oncology, Fundamental principles and clinical practice.Edinburgh:Churchil Livinstone, 1981:621-629.
  2. Woolas R, Jacob I. What is the true incidence of primary fallopian tube carcinoma? Int J Gynecol Cancer 199; 4:384-388.
  3. Goldman JA, Gans B, Eckerling B. Hydrops tubae profluens- a symptom in tubal carcinoma. Obstet Gynecol 1961; 18:631-634.
  4. Sedlis A. Primary carcinoma of the fallopian tube. Obstet Gynecol Surv 1961; 16:209-226.
  5. Sonnendecker HE, Cooper K, Kalian KN. Primary fallopian tube adenocarcinoma in situ associated with adjuvant tamoxifen therapy for breast carcinoma. Gynecol Oncol 1994; 52:402-407.
  6. Gaffney EF, Cornog J. Endometrioid carcinoma of the fallopian tube arising in endometrioisis. Obstet Gynecol 1978; 52:34s-36s.
  7. Daya D, Young RH, Scully RE. Endometrioid carcinoma of the fallopian tube resembling an adenxal tumor of probable wolffian origin. A report of six cases. Int J Gynecol Pathol 1992; 11:122-130.
  8. Hirai Y, Kaku S, Hamada T.  Clinical study of primary carcinoma of the fallopian tube. Experience with 15 cases. Gynecol Oncol 1989;34:20-26.
  9. Schiller HM, Silverberg SG. Staging and prognosis in primary carcinoma of the fallopian tube. Cancer 1971;28:383-395.
  10. Talamato S, Bender BL, Ellis LD, Scioscia EA. Adenocarcinoma of the fallopian tube. An ultrastuctural study. Virchows Arch [A] 1982; 397:363-368.

© Copyright 2007 - Iranian Journal of Reproductive Medicine


The following images related to this document are available:

Photo images

[rm07018f5.jpg] [rm07018f1.jpg] [rm07018f4.jpg] [rm07018f3.jpg] [rm07018f2.jpg]
Home Faq Resources Email Bioline
© Bioline International, 1989 - 2024, Site last up-dated on 01-Sep-2022.
Site created and maintained by the Reference Center on Environmental Information, CRIA, Brazil
System hosted by the Google Cloud Platform, GCP, Brazil